A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices

Completed · Phase 1

Conditions studied: Healthy

In brief

The main purpose of this study is to look at the amount of the study drug, LY3437943, that gets into the blood stream and how long it takes the body to get rid of it when given using two different devices. The study will also evaluate the safety and tolerability of LY3437943 and information about any side effects experienced will be collected. For each participant, the total duration of the study will be approximately 16 weeks, including screening.

Key facts

Study ID
NCT06003465
Run by
Eli Lilly and Company
People needed
57
Starts
2023-08-29
Expected to finish
2024-02-08
Last updated by the study team
2024-03-29

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.